24 September 2024
24 September 2024
The acquisition is a pivotal step in the company’s growth strategy to triple its respiratory diagnostics business by 2026.
The money comes after the company accelerated the global rollout of its delivery catheters and thrombectomy devices.
The results from three clinical trials showed that using the company’s HOPE perfusion device improves outcomes in redo-liver transplantation surgeries.
Findings from the ACTION PMR study suggest that Hyperfine’s Swoop system could enhance stroke diagnosis accessibility and efficiency.
The TAGS technology has PCR testing capabilities on high-throughput systems such as the cobas 5800, 6800, and 8800 models.
Synergia’s optoelectronic technology overcomes several hurdles for MRI compatibility.
The panel enables identification of single nucleotide variants, insertions, deletions, and copy number variations.
SSO₂ Therapy delivers a concentrated dose of oxygen directly to the damaged heart tissue following angioplasty.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
